
|Articles|November 15, 2002
Bone marrow-derived stem cells show potential for treating retinal diseases
La Jolla, CA-Results from murine studies indicate that a population of adult bone marrow-derived hematopoietic stem cells injected intravitreally will selectively target activated astrocytes, become incorporated into blood vessels, and promote or inhibit retinal angiogenesis, reported Martin Friedlander, MD, PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tensions rise between STAAR and Broadwood as proposed Alcon deal nears vote
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
4
AAO 2025: Arshad M. Khanani, MD, highlights 3-year results from the GATHER2 open-label extension trial
5